Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorMuro, Kei
dc.contributor.authorSalinardi, Taylor
dc.contributor.authorSingh, Arvind Rup
dc.contributor.authorMacarulla Mercadé, Teresa
dc.date.accessioned2021-09-20T13:06:24Z
dc.date.available2021-09-20T13:06:24Z
dc.date.issued2020-03-31
dc.identifier.citationMuro K, Salinardi T, Singh AR, Macarulla T. Safety of Aflibercept in Metastatic Colorectal Cancer: A Literature Review and Expert Perspective on Clinical and Real-World Data. Cancers. 2020 Mar 31;12:844.
dc.identifier.issn2072-6694
dc.identifier.urihttp://hdl.handle.net/11351/6333
dc.descriptionAflibercept; Teràpia anti-angiogènica; Càncer colorectal
dc.description.sponsorshipThis research was funded by Sanofi.
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofseriesCancers;12
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectProteïnes recombinants
dc.subjectCòlon - Càncer - Tractament
dc.subjectRecte - Càncer - Tractament
dc.subject.meshColorectal Neoplasms
dc.subject.mesh/drug therapy
dc.subject.meshRecombinant Fusion Proteins
dc.titleSafety of Aflibercept in Metastatic Colorectal Cancer: A Literature Review and Expert Perspective on Clinical and Real-World Data
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3390/cancers12040844
dc.subject.decsneoplasias colorrectales
dc.subject.decs/farmacoterapia
dc.subject.decsproteínas de fusión recombinantes
dc.relation.publishversionhttps://doi.org/10.3390/cancers12040844
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Muro K] Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya 464-8681, Japan. [Salinardi T, Singh AR] Global Medical Oncology, Sanofi, Boston, MA 02142, USA. [Macarulla T] Grup de Tumors gastrointestinals, Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. IOB, Barcelona, Spain
dc.identifier.pmid32244546
dc.identifier.pmid000535587400073
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple